RM Partners

What RM Partners does

RM Partners is one of 20 NHS Cancer Alliances formally established by NHS England to lead delivery of the cancer care recommendations in the NHS Long Term Plan. Hosted by The Royal Marsden NHS Foundation Trust and headquartered at 6th Floor, National Audit Office, 157-197 Buckingham Palace Road, London, RM Partners coordinates cancer care transformation across north west and south west London, covering 14 boroughs including Hammersmith & Fulham, Hillingdon, Hounslow, Merton, Sutton, Wandsworth, and Croydon. The organisation works through 14 NHS trusts, hundreds of GP practices, mobile CT scanning units, and a community grant programme that has funded 119 community organisations to deliver cancer awareness activities.

The organisation's portfolio spans prevention and screening (HPV vaccination, bowel, breast, cervical, and lung cancer screening via mobile units), diagnostic and treatment pathway improvement (RAPID prostate pathway using mp-MRI and transperineal fusion biopsy; Lynch Syndrome quality improvement; Rapid Diagnostic Cancer Clinics for non-specific symptoms; ACCESS liquid biopsy project using Guardant360 for pancreatic and biliary tract cancers across six West London trusts), personalised cancer care, treatment networks (West London, Surrey & Sussex Radiotherapy ODN; Children's, Teenagers' and Young Adults Cancer ODN), research and innovation (Research and Innovation Fund; Pan-London Cancer Alliances Research Fellowships now in its 8th+ year), and community engagement including the Cancer SMART service for patients with severe mental illness. Notable technical components include the NWL Cervical Screening Dashboard, electronic safety netting tools in primary care, and AI-assisted decision support tools.

RM Partners operates as a publicly funded NHS coordination body rather than a commercial enterprise. It does not sell products or services; all cancer screening, diagnosis, and treatment it supports is provided free at point of use through the NHS. Funding flows from NHS England as part of the Cancer Alliance programme, supplemented by grants such as SBRI Healthcare funding (2021) and partnership contributions. Revenue is not publicly disclosed. The organisation ranked #1 Cancer Alliance nationally for delivery of the 62-day cancer treatment standard and has received the HSJ Award for Acute Sector Innovation (2018) for the RAPID prostate pathway and Bronze at The Drum Marketing Awards (2026) for its 'Don't Wipe Away The Signs' bowel cancer awareness campaign. Leadership comprises Managing Director Susan Sinclair, Deputy Medical Director Dr Lucy Hollingworth, and a small core team of 11-50 employees overseeing an extensive multi-stakeholder delivery network.

Name

RM Partners

Legal name

RM Partners

Website

https://rmpartners.nhs.uk

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

RM Partners is one of 20 NHS Cancer Alliances coordinating cancer care transformation across 14 boroughs in north west and south west London. It works with 14 NHS trusts, GP practices, and community organisations to deliver screening, diagnostic, treatment, and research programmes for the west London population.

Ownership category

akta.pro rank

Product category

Healthcare Coordination Services

NAICS

Other Individual and Family Services (624190), Offices of Physicians (62111)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Cancer care coordination
• Cancer screening programmes
• Diagnostic pathway redesign
• Oncology service improvement
• Healthcare alliance management

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. NHS England Cancer Alliance Funding: RM Partners is one of 20 Cancer Alliances established by NHS England to lead delivery of cancer care recommendations in the NHS Long Term Plan. As an NHS-funded body, it operates as a coordination and transformation entity rather than a revenue-generating organization. Funding supports cancer transformation projects, early diagnosis initiatives, workforce development, and innovation projects across partner NHS trusts in north west and south west London.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels12 records

Core offering

RM Partners coordinates cancer care transformation across north west and south west London on behalf of NHS England, delivering cancer screening programmes (bowel, breast, cervical, HPV vaccination, lung health checks), redesigned diagnostic and treatment pathways (including the award-winning RAPID prostate pathway and Rapid Diagnostic Centres), personalised care services, research and innovation funding, and community engagement initiatives to improve earlier diagnosis and reduce inequalities across 14 west London boroughs.

Product overview

RM Partners is one of 20 NHS Cancer Alliances established by NHS England to lead delivery of cancer care recommendations in the NHS Long Term Plan. It is not a single software product but a coordinated programme of cancer care services across north west and south west London. The organisation provides a comprehensive portfolio of programmes including: cancer screening initiatives (bowel, breast, cervical, HPV vaccination, lung cancer screening); diagnostic pathways (Rapid Diagnostic Centres, RAPID prostate pathway, Lynch Syndrome programme); treatment and care services (radiotherapy ODN, children's and young adults' cancer services, personalised cancer care, SACT); research and innovation programmes (Research and Innovation Fund, Pan-London Research Fellowships, ACCESS liquid biopsy project); and community engagement initiatives (Community Grant Programme, Cancer SMART service, Man Van mobile health clinic, 5K Your Way groups). The organisation also coordinates digital solutions and pathway groups across multiple tumour types.

Differentiator

Problem solved

Functional benefit

Products and services

• HPV Vaccination Campaign A comprehensive vaccination awareness campaign delivered to increase HPV vaccination uptake across north west and south west London, including in-school campaigns targeting teenagers.
• Bowel Cancer Screening Programme Initiatives to improve participation in bowel cancer screening, including reminder services, community engagement, and the award-winning 'Don't Wipe Away The Signs' awareness campaign.
• Breast Cancer Screening Programme Programmes to improve participation in breast cancer screening, including targeted outreach to underserved communities such as South Asian women.
• Cervical Screening Programme Initiatives to increase cervical screening participation, including social media campaigns, influencer partnerships, TikTok campaigns, and easier access to screening clinics.
• Lynch Syndrome Quality Improvement Project Quality improvement programme to assist healthcare professionals in testing patients for Lynch syndrome to improve prevention, identification, and early detection of colorectal and endometrial cancer, with online training hosted on NHS Learning Hub.
• Rapid Diagnostic Centres (RDCs) Non-specific symptoms Rapid Diagnostic Cancer Clinics programme providing faster diagnostic pathways for patients with concerning symptoms that could indicate cancer.
• Tumour-Specific Cancer Pathways Streamlined care pathways for specific cancer types including colorectal, lung, urological, gynaecological, and skin cancers.
• RAPID Prostate Pathway Rapid Assessment Prostate Imaging and Diagnosis pathway providing a one-stop diagnostic service for suspected prostate cancer using multi-parametric MRI and transperineal fusion biopsy, reducing infection risk and accelerating time to diagnosis.
• West London, Surrey & Sussex Radiotherapy Operational Delivery Network Operational Delivery Network coordinating radiotherapy services across west London, Surrey, and Sussex.
• Children's, Teenagers' and Young Adults' Cancer Operational Delivery Network Operational Delivery Network for young cancer patients, hosted by RM Partners, providing age-appropriate care pathways including fertility preservation services.
• Targeted Lung Health Check Programme Targeted Lung Health Check Programme offering free NHS lung health checks to past and current smokers aged 55–74, including mobile CT scanning units deployed at supermarket car parks, sports stadiums, and town centres across west London boroughs.
• Personalised Cancer Care Programme Comprehensive personalised care programmes including Holistic Needs Assessment, Treatment Summaries, Health and Wellbeing support, and Physical Activity resources for people affected by cancer.
• Research and Innovation Fund Funding programme supporting cancer researchers and clinicians to deliver projects improving earlier diagnosis, survival of rarer cancers, and addressing equity in access and outcomes.
• Pan-London Cancer Alliances Research Fellowships 12-month research fellowships programme across London's Cancer Alliances (now in 8th+ year) focusing on early diagnosis, cancer inequalities, and personalised care.
• ACCESS Project (Liquid Biopsy) Project embedding liquid biopsies using the Guardant360 test panel in diagnostic pathways for pancreatic and biliary tract cancer patients at six West London NHS Trusts, enabling faster, more personalised treatment.
• Community Grant Programme Funding programme offering grants (up to £4,000) to community and voluntary organisations to deliver cancer awareness activities across north west and south west London, with 119 grants awarded and 198 events scheduled.
• Cancer SMART Service Severe Mental Illness Access and Rapid Treatment service at St George's Hospital supporting cancer patients with psychosis, schizoaffective disorder, or bipolar affective disorder, integrating mental health support with cancer care.
• Man Van Mobile Health Clinic Mobile health clinic providing free men's health checks to speed up cancer diagnoses and improve healthcare access, delivered at workplaces across west London.
• Senior Adult Oncology Programme Programme to improve care for older cancer patients, delivering personalised care for breast cancer patients over 70 years of age at The Royal Marsden NHS Foundation Trust.
• Systemic Anti-Cancer Therapy (SACT) Programme Programmes supporting SACT delivery across west London, including the Pan-London SACT Verification Passport for Pharmacy originally produced by RM Partners and subsequently rolled out UK-wide by the British Oncology Pharmacy Association (BOPA).
• Pan-London Haemato-Oncology Clinical Guidelines Jointly published clinical guidelines for haematological cancers across London's Cancer Alliances, supporting standardised clinical practice.

Quantifiable outcome

• Ranked #1 Cancer Alliance nationally for delivery of the 62-day cancer treatment standard
• +9 more outcomes

Named customers11 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

23 partnerships are on record, tiered core, notable and minor.

• The Royal Marsden NHS Foundation TrustcoreStrategic or Co-development PartnerThe Royal Marsden NHS Foundation Trust is a core alliance member and the host organisation for RM Partners. It provides clinical leadership and hosts major cancer transformation programmes including the RAPID prostate pathway pilot, liquid biopsy ACCESS project, and Senior Adult Oncology Programme. The Royal Marsden is one of the world's leading cancer hospitals and provides academic and research partnership through its Academic Health Science Centre status with The Institute of Cancer Research (ICR).
• NHS EnglandcoreStrategic or Co-development PartnerNHS England established the 20 Cancer Alliances including RM Partners to lead delivery of the NHS Long Term Plan's cancer care recommendations. NHS England provides funding, national policy direction, and programme oversight. RM Partners participates in national initiatives including the NHS Targeted Lung Health Check Programme, Cancer Innovation Open Call, and National Cancer Patient Experience Survey.
• St George's University Hospitals NHS Foundation TrustcoreStrategic or Co-development PartnerHost site for Rapid Diagnostic Cancer Clinics, South West London Cancer Clinical Director leadership, Cancer SMART service pilot for patients with severe mental illness, World Cancer Day events, and lymph node biopsy and other cancer treatment pathways. Key NHS trust partner across south west London.
• Imperial College Healthcare NHS TrustcoreStrategic or Co-development PartnerHost trust for the North West London Cancer CNS Development Lead post and one of three pilot sites for the RAPID prostate pathway (Charing Cross Hospital). Academic NHS trust providing leadership in urology (Professor Hashim Ahmed), radiology, and cancer diagnostics.
• Royal Brompton Hospital (part of The Royal Marsden NHS Foundation Trust)coreStrategic or Co-development PartnerLead NHS Trust for the west London Lung Health Checks programme. Dr Emily Bartlett, consultant radiologist, led the clinical team providing demonstrations and clinical oversight for the mobile CT scanning units deployed across west London boroughs.
• Chelsea and Westminster Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerSite for the RAPID prostate pathway pilot, the Symplify liquid biopsy clinical trial, the new Chelsea Anogenital Neoplasia Service (CANS), and oncology pharmacy education. Contributed to medicines optimisation pathway group.
• Croydon Health Services NHS TrustcoreStrategic or Co-development PartnerHost trust for the South West London Cancer CNS Development Lead post. Site for the Cytosponge pilot for oesophageal cancer diagnosis and multidisciplinary cancer clinics.
• Pan-London Cancer Alliances Research ConsortiumcoreStrategic or Co-development PartnerRM Partners collaborates with North Central London Cancer Alliance, South East London Cancer Alliance, and other Cancer Alliances on the pan-London cancer research fellowship programme (now in its 8th+ year), haematology-oncology clinical guidelines, and pan-London cervical cancer elimination initiative with NHS England's ambition to eliminate cervical cancer by 2040.
• Jack Ryan (Creative Agency)notableGTM or Marketing PartnerCreative agency partner for the 'Don't Wipe Away The Signs' bowel cancer awareness campaign that won bronze at the Drum Marketing Awards 2026. The partnership developed bold and engaging creative approaches including the NHS's first 3D bowel cancer awareness billboard.
• Macmillan Cancer SupportnotableStrategic or Co-development PartnerCharitable partner providing support for cancer patient resources, cancer care reviews, and co-funding the CNS Development Leads pilot alongside NHS England. Collaboration on patient information films and cancer support initiatives.
• Jo's Cervical Cancer TrustnotableStrategic or Co-development PartnerCharitable partner collaborating on pan-London cervical cancer prevention campaigns during Cervical Cancer Prevention Week, working with the four London Cancer Alliances on public awareness initiatives to increase cervical screening uptake.
• Heartburn Cancer UKminorStrategic or Co-development PartnerCharity partner for pan-London oesophageal cancer awareness campaign during Oesophageal Cancer Awareness Month, collaborating with RM Partners to raise awareness of oesophageal cancer symptoms and risk factors.
• Groundswell (Homelessness Charity)notableStrategic or Co-development PartnerCommissioned by the four NHS Cancer Alliances in London to develop cancer screening guides for people experiencing homelessness. Groundswell produced tailored guides for bowel, breast, and cervical screening in accessible formats for this underserved population.
• Jnetics and Chai Cancer CareminorStrategic or Co-development PartnerJewish community charities working with NHS England to raise awareness and encourage participation in the national BRCA gene testing programme for people with Jewish ancestry (those with at least one Jewish grandparent, 6x more likely to carry BRCA gene faults).
• Better Leisure Centres (Gym Chain)minorGTM or Marketing PartnerPartnership with NHS England to place 'Check you out' cancer awareness stickers on changing room and gym mirrors in Better leisure centres across England, reaching gym-goers with 'Know what's normal for you' messaging.
• World Cancer Research FundminorStrategic or Co-development PartnerPartner referenced for the launch of a new nutrition helpline for people living with cancer, providing expert oncology dietitian support for patients experiencing taste changes, appetite loss, nausea, and other treatment side effects.
• The Institute of Cancer Research (ICR)coreStrategic or Co-development PartnerAcademic research partner alongside The Royal Marsden NHS Foundation Trust, providing biomedical research centre (BRC) support for the Pan-London cancer research fellowship programme and cancer research innovation.
• Action Bladder Cancer UK (ABC UK)minorStrategic or Co-development PartnerCharity partner for the bladder cancer awareness campaign (September 2025), developing campaign materials targeting people over 50, women, lower socio-economic groups, and Black and South Asian communities who experience health inequalities.
• Croydon MencapminorStrategic or Co-development PartnerPartner for development of an Easy Read version of the RM Partners 5-year cancer strategy, making cancer strategy information accessible to people with learning disabilities.
• Move Against Cancer / 5K Your WayminorStrategic or Co-development PartnerCharity partnership supporting the 5K Your Way programme — community-based groups meeting at designated parkruns on the last Saturday of each month to support those living with and beyond cancer. RM Partners supported launch of groups in Croydon (100th UK group) and Harrow.
• Pan-London SACT Verification Passport — British Oncology Pharmacy Association (BOPA)notableStrategic or Co-development PartnerThe Pan-London SACT Verification Passport for Pharmacy, originally produced by RM Partners, was updated and rolled out UK-wide by the British Oncology Pharmacy Association (BOPA) as the BOPA Digital SACT Verification Passport supporting chemotherapy verification across adult and paediatric solid tumour and haematology services.
• London and South East Sarcoma Network (LSESN)minorStrategic or Co-development PartnerRM Partners participates in the LSESN alongside The Royal Marsden, University College London Hospitals, and Royal National Orthopaedic Hospital, running sarcoma awareness events and developing multidisciplinary clinical team coordination for sarcoma patients.
• Pfizer LimitedminorStrategic or Co-development PartnerCollaborative working project between RM Partners West London Cancer Alliance and Pfizer Limited focused on improving Multi-Disciplinary Team (MDT) meeting effectiveness and operational efficiency.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Others

• Macmillan Cancer Support: Major UK cancer charity that co-funds RM Partners' Cancer CNS Development Lead pilot and co-produces patient resources. Comparable as a UK-wide cancer support organisation that operates alongside NHS Cancer Alliances in personalised care, patient information, and workforce development.
• NHS England (Cancer Programme): The parent/funder of all 20 Cancer Alliances, including RM Partners. While NHS England sets policy and funding rather than competing, it is the primary stakeholder comparator for understanding the national governance, funding envelope, and policy direction within which RM Partners operates.
• The Royal Marsden NHS Foundation Trust: Host trust for RM Partners and one of the world's leading specialist cancer hospitals. While not a peer Cancer Alliance, it is the most operationally intertwined partner, providing clinical leadership, the BRC with the Institute of Cancer Research, and senior staff embedded in RM Partners' leadership and programmes.
• Cancer Research UK: The UK's largest cancer research and awareness charity. While not a Cancer Alliance, it is a relevant ecosystem peer as a national body that funds cancer research, runs screening awareness campaigns, and partners with NHS bodies on early diagnosis initiatives similar to those coordinated by RM Partners.

Direct peers

• Greater Manchester Cancer Alliance: An NHS Cancer Alliance covering Greater Manchester, with similar responsibilities for cancer pathway redesign, early diagnosis programmes, and screening uptake. Directly comparable as a peer NHS Cancer Alliance operating under the same national framework but in a different integrated care system context.
• South East London Cancer Alliance: One of the four London NHS Cancer Alliances, covering south east London boroughs. Directly comparable as a sister Cancer Alliance coordinating cancer transformation, screening uptake, and diagnostic pathway redesign within the same pan-London Research Consortium and joint campaigns such as the cervical cancer elimination initiative.
• West Midlands Cancer Alliance: One of the 20 NHS Cancer Alliances operating outside London, covering the West Midlands region. Directly comparable as a peer NHS Cancer Alliance delivering early diagnosis, screening improvement, and personalised care initiatives under the same NHS Long Term Plan framework.
• North Central London Cancer Alliance: Another of the 20 NHS Cancer Alliances, covering north central London boroughs (Camden, Islington, Barnet, Enfield, Haringey). Directly comparable as a peer NHS England-established cancer coordination body delivering the NHS Long Term Plan cancer recommendations within the same pan-London ecosystem, including collaboration on the Pan-London Cancer Alliances Research Consortium.

Regional players

• Imperial College Health Partners: An academic health science network in north west London that collaborates with Imperial College Healthcare NHS Trust on research, innovation, and population health. Comparable as a regional health system partner that works with the same north west London NHS trusts and primary care networks that RM Partners coordinates, often on shared projects such as the RAPID prostate pathway.
• King's Health Partners Integrated Cancer Centre: An academic health science centre cancer programme covering south east London, including Guy's and St Thomas', King's College Hospital, and the Institute of Cancer Research. Comparable as a London-based integrated cancer care and research entity that overlaps with the South East London Cancer Alliance footprint and engages in similar pathway transformation work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• Xx.com/RMPartnersNHS
• YouTubeyoutube.com/channel/UC1hD1FTskGYLuSbp6_xEWIA
• LinkedInlinkedin.com/company/rm-partners-nhs-cancer-alliance
• Instagraminstagram.com/rmpartnersnhs

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RM Partners